Skip Navigation
  • May is ALS Awareness Month
    May is ALS Awareness Month!
    Make a gift in May to support ALS Research
  • FDA grants accelerated approval of tofersen for treatment of SOD1-ALS
    Drug’s development stemmed from collaborative research from Packard Center investigators.
    Read more:
  • Artificial intelligence-driven platform identifies new ALS gene targets
    Twenty-eight targets were identified, and the collaborative study was led by Insilico with support from Answer ALS and researchers at nine institutions including the Johns Hopkins University School of Medicine
    Read more:
  • The Pathway to Discovery and Hope for ALS Patients and Researchers: A massive biological genetic and clinical resource for ALS and neurodegenerative diseases.
    Massive Answer ALS resource paper is published in Nature Neuroscience.
    Read more about this groundbreaking study:
       

What is ALS?

Amyotrophic lateral sclerosis (ALS), also known as called Lou Gehrig's, disease is a rapidly progressive, fatal neurological disease that attacks the nerve cells (neurons) responsible for controlling voluntary muscles.  The average life span from diagnosis is two to five years.  There is no cure.

Understanding ALS

Our mission is to fund and support ALS research around the world
Our goal is to find a cure

Meet the Packard Center Team

 
Packard Center Donors
One family's commitment to ALS research inspires hope.
 
ALS Patients
Two men, fighting ALS with passion and determination.
Packard Research Projects
150 Scientists
27 Projects
18 Institutions
5 Countries
Working together to find a cure.
Explore our Research
Join the Family - Get Involved

You can make a difference. Tell us your story. Get involved. Make a Gift.
The hope is in the science.